Enliven Therapeutics Inc.

NASDAQ: ELVN · Real-Time Price · USD
20.24
0.47 (2.38%)
At close: Aug 15, 2025, 3:59 PM
20.22
-0.10%
After-hours: Aug 15, 2025, 06:46 PM EDT

Enliven Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-89.02M -71.58M -37.66M -24.74M
Depreciation & Amortization
317K 297K 215K 115K
Stock-Based Compensation
20.17M 12.91M 3.19M 1.92M
Other Working Capital
-5.35M 3.65M 27K 1.83M
Other Non-Cash Items
-118K -4.3M 1.74M 3.81M
Deferred Income Tax
n/a n/a n/a -3.81M
Change in Working Capital
-4.54M 1.4M 438K 3.57M
Operating Cash Flow
-73.19M -61.27M -32.08M -19.13M
Capital Expenditures
-44K -149K -612K -191K
Cash Acquisitions
n/a n/a 35M n/a
Purchase of Investments
-350.74M -268.26M -35M -47.56M
Sales Maturities Of Investments
313.91M 120M 41.88M 45.94M
Other Investing Acitivies
873K n/a -41.88M 1.62M
Investing Cash Flow
-36M -148.41M -612K -191K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
93.98M 73.08M -566K n/a
Financial Cash Flow
133.16M 234.29M -1.8M -1.02M
Net Cash Flow
23.98M 24.61M -34.49M -20.34M
Free Cash Flow
-73.24M -61.42M -32.69M -19.32M